Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May;7(1):77-82.
doi: 10.1007/s13730-017-0299-5. Epub 2017 Dec 29.

Complete remission of hypertension in a hemodialysis patient after adrenalectomy for primary aldosteronism and renal transplantation

Affiliations

Complete remission of hypertension in a hemodialysis patient after adrenalectomy for primary aldosteronism and renal transplantation

Daisuke Watanabe et al. CEN Case Rep. 2018 May.

Abstract

A 64-year-old man was admitted to our hospital for the hormonal evaluation of a right adrenal adenoma. He had been diagnosed with severe proteinuria and hypertension, and antihypertensive treatment was started at the age of 60. His renal function gradually declined, and hemodialysis was begun at the age of 64. Since his blood pressure was uncontrollable and resistant to antihypertensive treatment, an endocrinological examination was performed for an incidental right adrenal mass detected by computed tomography. The results of screening, including captopril challenge and an adrenocorticotropin stimulation test for primary aldosteronism, and adrenal venous sampling suggested excessive aldosterone secretion from the right adrenal gland. Adrenalectomy was performed; his blood pressure decreased and became well-controlled with a reduced antihypertensive regimen. Furthermore, he received renal transplantation which resulted in normalization of his serum potassium level, improvement of renal function and hormonal levels such as plasma renin activity and aldosterone concentration, and satisfactory blood pressure without any antihypertensive medications. This case is extremely important to demonstrate the effects of adrenalectomy for primary aldosteronism in a hemodialysis patient. It is possible that adrenalectomy may be a useful treatment for primary aldosteronism even in patients undergoing hemodialysis. Careful long-term follow-up of our case and investigations of the efficacy of adrenalectomy in similar cases are needed to address this issue.

Keywords: Aldosterone; Blood pressure; End-stage renal disease; Renin; Surgery.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

All the authors have declared no competing interest.

Human and animal rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Informed consent was obtained from all the individual participants included in the study.

Figures

Fig. 1
Fig. 1
Abdominal computed tomography. Arrow indicates a low-density tumor on the right adrenal gland
Fig. 2
Fig. 2
Pathological examination of the resected right adrenal specimen. a Macroscopic feature of the cut surface showed a bright yellowish solid mass, measuring 1.4 cm × 1.0 cm across. b Adrenal mass was composed mainly of clear cells (hematoxylin and eosin stain, scale bar is 100 µm). c Immunohistochemical staining showed compact cells were positive for CYP11B2 (dilution of 1:20, scale bar is 100 µm)
Fig. 3
Fig. 3
Clinical course of the current case. Filled diamond, systolic blood pressure; filled square, diastolic blood pressure. CCB calcium channel blocker, ARB angiotensin II receptor blocker, PAC plasma aldosterone concentration, PRA plasma renin activity, sBP systolic blood pressure, dBP diastolic blood pressure

References

    1. Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, Stowasser M, Young WF., Jr The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889–1916. doi: 10.1210/jc.2015-4061. - DOI - PubMed
    1. Prejbisz A, Warchol-Celinska E, Lenders JW, Januszewicz A. Cardiovascular risk in primary hyperaldosteronism. Horm Metab Res. 2015;47:973–980. doi: 10.1055/s-0035-1565124. - DOI - PubMed
    1. Nishimura M, Uzu T, Fujii T, Kuroda S, Nakamura S, Inenaga T, Kimura G. Cardiovascular complications in patients with primary aldosteronism. Am J Kidney Dis. 1999;33:261–266. doi: 10.1016/S0272-6386(99)70298-2. - DOI - PubMed
    1. Sechi LA, Di Fabio A, Bazzocchi M, Uzzau A, Catena C. Intrarenal hemodynamics in primary aldosteronism before and after treatment. J Clin Endocrinol Metab. 2009;94:1191–1197. doi: 10.1210/jc.2008-2245. - DOI - PMC - PubMed
    1. Sechi LA, Novello M, Lapenna R, Baroselli S, Nadalini E, Colussi GL, Catena C. Long-term renal outcomes in patients with primary aldosteronism. JAMA. 2006;295:2638–2645. doi: 10.1001/jama.295.22.2638. - DOI - PubMed

LinkOut - more resources